AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34981344 — intervention group
Group type: EXPERIMENTAL
Intervention: DEG measure
Number of subjects: 312
Study 34981344 — intervention group
Group type: COMPARATOR
Intervention: Patients with NYHA 1-2
Number of subjects: 312
Study 34981344 — intervention group
Group type: COMPARATOR
Intervention: Patients without comorbid COPD
Number of subjects: 312
Study 33960833 — intervention group
Group type: EXPERIMENTAL
Intervention: PRISM intervention group
Number of subjects: 86
Study 33960833 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study 35148512 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-kHz spinal cord stimulation (SCS)
Number of subjects: 159
Study 35148512 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical management (CMM)
Number of subjects: 159
Study 35148512 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover arm (after CMM)
Number of subjects: 159
Study 35148512 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study results
Number of subjects: 159
Study 33020846 — intervention group
Group type: EXPERIMENTAL
Intervention: Connected monitoring
Number of subjects: 94
Study 33020846 — intervention group
Group type: COMPARATOR
Intervention: Conventional monitoring
Number of subjects: 94
Study 32602803 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted brief intervention delivered in Spanish by promotores in a community setting
Number of subjects: 73
Study 32602803 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted brief intervention
Number of subjects: 73
Study 33947827 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week individual-based multimodal program of task-oriented exercises integrated with cognitive-behavioral therapy
Number of subjects: 150
Study 33947827 — intervention group
Group type: COMPARATOR
Intervention: Individual-based general physiotherapy
Number of subjects: 150
Study 35807780 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet (DI; n = 13)
Number of subjects: 45
Study 35807780 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and Diet (EX + DI; n = 16)
Number of subjects: 45
Study 35807780 — intervention group
Group type: COMPARATOR
Intervention: Control (CON; n = 16)
Number of subjects: 45
Study 32838584 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine development efforts against sexually transmitted viruses (STVs)
Number of subjects: 0
Study 32838584 — intervention group
Group type: EXPERIMENTAL
Intervention: Various approaches for improving prophylactic or therapeutic vaccines
Number of subjects: 0
Study 33141209 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=326)
Number of subjects: 840
Study 33141209 — intervention group
Group type: COMPARATOR
Intervention: Online program only (n=216)
Number of subjects: 840
Study 33141209 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (n=298)
Number of subjects: 840
Study 35360148 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Community Exercise Programme (DCEP) plus usual care
Number of subjects: 165
Study 35360148 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 165
Study 32049228 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Brief Intervention (GBI)
Number of subjects: 180
Study 32049228 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 180
Study 32049228 — intervention group
Group type: COMPARATOR
Intervention: Comparison between EG and CG
Number of subjects: 180
Study 36495093 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum lactate-based antiperspirant
Number of subjects: 50
Study 36495093 — intervention group
Group type: COMPARATOR
Intervention: Aluminum chloride-based antiperspirant
Number of subjects: 50
Study 34021038 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rivaroxaban 2.5 mg two times per day and aspirin 100 mg once daily
Number of subjects: 18278
Study 34021038 — intervention group
Group type: COMPARATOR
Intervention: Non-study aspirin
Number of subjects: 18278
Study 32539812 — intervention group
Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (c‐tDCS) combined with virtual reality (VR)
Number of subjects: 40
Study 32539812 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation combined with virtual reality (VR)
Number of subjects: 40
Study 34735312 — intervention group
Group type: EXPERIMENTAL
Intervention: ANODAL tDCS
Number of subjects: 32
Study 34735312 — intervention group
Group type: EXPERIMENTAL
Intervention: CATHODAL tDCS
Number of subjects: 32
Study 34735312 — intervention group
Group type: COMPARATOR
Intervention: SHAM tDCS
Number of subjects: 32
Study 32183778 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic transcystic dilation of the cystic duct confluence in CBD exploration (LTD-CBDE)
Number of subjects: 68
Study 32183778 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic common bile duct exploration (LCBDE)
Number of subjects: 68
Study 34670132 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-guided treatment with escitalopram (AGT-E)
Number of subjects: 987
Study 34670132 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-guided treatment with mirtazapine (AGT-M)
Number of subjects: 987
Study 34670132 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 987
Study 32647911 — intervention group
Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI
Number of subjects: 10355
Study 36122588 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IHMs)
Number of subjects: 60
Study 36122588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34419131 — intervention group
Group type: EXPERIMENTAL
Intervention: Newspaper advertisements
Number of subjects: 226
Study 34419131 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical referrals
Number of subjects: 226
Study 34419131 — intervention group
Group type: EXPERIMENTAL
Intervention: Web advertisements
Number of subjects: 226
Study 34419131 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based strategies (advertisement and flyers)
Number of subjects: 226
Study 34419131 — intervention group
Group type: COMPARATOR
Intervention: Various recruitment strategies
Number of subjects: 226
Study 32234000 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of omeprazole enteric-coated tablet 20 mg
Number of subjects: 48
Study 32234000 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of omeprazole
Number of subjects: 48
Study 35486415 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 60
Study 35486415 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexmedetomidine)
Number of subjects: 60
Study 34224994 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose IFN-β 1a (88 μg on days 1, 3, 6) + lopinavir/ritonavir (400 mg/100 mg twice a day for 10 days)
Number of subjects: 168
Study 34224994 — intervention group
Group type: COMPARATOR
Intervention: Low-dose IFN-β 1a (44 μg on days 1, 3, 6) + lopinavir/ritonavir (400 mg/100 mg twice a day for 10 days)
Number of subjects: 168
Study 34224994 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose IFN-β 1a
Number of subjects: 168
Study 34224994 — intervention group
Group type: COMPARATOR
Intervention: Low-dose IFN-β 1a
Number of subjects: 168
Study 33938926 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted clinical pharmacist intervention
Number of subjects: 459
Study 36107972 — intervention group
Group type: EXPERIMENTAL
Intervention: ICE (450 g of -2°C ice slurry)
Number of subjects: 12
Study 36107972 — intervention group
Group type: COMPARATOR
Intervention: CON (30°C beverage)
Number of subjects: 12
Study 36107972 — intervention group
Group type: COMPARATOR
Intervention: WAT (30°C water)
Number of subjects: 12
Study 33179395 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone plus Tacrolimus (TAC)
Number of subjects: 58
Study 33179395 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone plus Cyclosporin A (CsA)
Number of subjects: 58
Study 33179395 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TAC and CsA)
Number of subjects: 58
Study 35668002 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA
Number of subjects: 27
Study 35668002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 32245746 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 56
Study 32245746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 34628939 — intervention group
Group type: EXPERIMENTAL
Intervention: HSAT
Number of subjects: 250
Study 34628939 — intervention group
Group type: COMPARATOR
Intervention: iPSG
Number of subjects: 250
Study 33950949 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) plus chemotherapy (Kang Ai injection, herbal decoction, Zhenqifuzheng capsules)
Number of subjects: 75
Study 33950949 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 75
Study 34214231 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation
Number of subjects: 39
Study 34214231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 33864994 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm salt water foot bath for 20 minutes for a week
Number of subjects: 75
Study 33864994 — intervention group
Group type: COMPARATOR
Intervention: Control group (received a training booklet about chemotherapy-induced fatigue)
Number of subjects: 75
Study 34482505 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich ultrapure water (HRW) 500 mg of nickel chloride kg‐1 soil for 14 days
Number of subjects: 0
Study 34482505 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich ultrapure water (HRW) 200 mg of nickel chloride kg‐1 soil for 14 days
Number of subjects: 0
Study 34482505 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich ultrapure water (HRW)
Number of subjects: 0
Study 34482505 — intervention group
Group type: COMPARATOR
Intervention: Control group (CW: ultrapure water)
Number of subjects: 0
Study 34280934 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to standardized classical music (n = 35)
Number of subjects: 127
Study 34280934 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music of patients' own choice (n = 34)
Number of subjects: 127
Study 34280934 — intervention group
Group type: COMPARATOR
Intervention: No music (control group III, n = 44)
Number of subjects: 127
Study 32939556 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine intake (5-100 mg·kg‐1·d‐1) during late gestation
Number of subjects: 17
Study 32939556 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine intake (5-100 mg·kg‐1·d‐1) during midgestation
Number of subjects: 17
Study 32246748 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement device (MAD)
Number of subjects: 64
Study 32246748 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 64
Study 32246748 — intervention group
Group type: COMPARATOR
Intervention: Intra-oral placebo appliance
Number of subjects: 64
Study 34226226 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral furosemide 80 mg/day (adjusted to 160 mg/day if urine volume < 400 mL/day after 2 weeks)
Number of subjects: 560
Study 34226226 — intervention group
Group type: COMPARATOR
Intervention: Blank control group
Number of subjects: 560
Study 34348606 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors
Number of subjects: 0
Study 34348606 — intervention group
Group type: COMPARATOR
Intervention: Standard evidence-based therapies
Number of subjects: 0
Study 32715937 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) classifier used to predict treatment effect perception based on primary endpoints and judges' evaluations.
Number of subjects: 50
Study 32715937 — intervention group
Group type: EXPERIMENTAL
Intervention: Nine primary endpoints relating to skin pores assessed by a specific image analysis algorithm.
Number of subjects: 50
Study 32715937 — intervention group
Group type: EXPERIMENTAL
Intervention: Bradley-Terry model for intra-study product ranking based on mean judges' predicted preference.
Number of subjects: 50
Study 32300002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) and relaxation techniques administered by non-specialist providers, with six individual sessions and two to six booster sessions.
Number of subjects: 0
Study 33320779 — intervention group
Group type: EXPERIMENTAL
Intervention: MIE (moderate-intensity exercise)
Number of subjects: 11
Study 36114653 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone monoester supplementation (27 g per dose, thrice daily)
Number of subjects: 16
Study 36114653 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric maltodextrin placebo
Number of subjects: 16
Study 32993754 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensatory Cognitive Training (CCT)
Number of subjects: 100
Study 32993754 — intervention group
Group type: COMPARATOR
Intervention: Computerised Interactive Remediation of Cognition‐Training for Schizophrenia (CIRCuiTS)
Number of subjects: 100
Study 35505387 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 0
Study 35505387 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32304248 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTG from tuberosity area (TG)
Number of subjects: 29
Study 32304248 — intervention group
Group type: COMPARATOR
Intervention: SCTG from lateral palate (CG)
Number of subjects: 29
Study 36047276 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36047276 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent approaches
Number of subjects: 0
Study 32149579 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol 1,000 IU/day
Number of subjects: 92
Study 32149579 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 200,000 IU injection (equivalent to 2,000 IU/day)
Number of subjects: 92
Study 32149579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 32252707 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered Acceptance and Commitment Therapy (IACT)
Number of subjects: 11
Study 32252707 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist guidance and deadlines for homework
Number of subjects: 11
Study 32252707 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusting treatment content and format based on participants' characteristics
Number of subjects: 11
Study 36120427 — intervention group
Group type: EXPERIMENTAL
Intervention: pioglitazone 45 mg/day
Number of subjects: 24
Study 36120427 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 34501562 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Breaks videos for a period of four months
Number of subjects: 70
Study 34501562 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 70
Study 32713367 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT + low-frequency right prefrontal rTMS
Number of subjects: 35
Study 32713367 — intervention group
Group type: COMPARATOR
Intervention: ECT + placebo
Number of subjects: 35
Study 35353424 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender-Rights Awareness Arm
Number of subjects: 0
Study 35353424 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based skills training program
Number of subjects: 0
Study 35353424 — intervention group
Group type: COMPARATOR
Intervention: Baseline and endline assessments
Number of subjects: 0
Study 33127467 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Activity (AA)
Number of subjects: 201
Study 33127467 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 201
Study 33369451 — intervention group
Group type: EXPERIMENTAL
Intervention: Protection motivation theory-based intervention
Number of subjects: 360
Study 34896442 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch-and-rinse (ER) strategy
Number of subjects: 35
Study 34896442 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch (SE) strategy
Number of subjects: 35
Study 34896442 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ER and SE strategies
Number of subjects: 35
Study 34124926 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias modification for interpretation bias (CBM‐I)
Number of subjects: 135
Study 34124926 — intervention group
Group type: COMPARATOR
Intervention: Active control (AC)
Number of subjects: 135
Study 34654028 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV‐BF with 0.1‐Hz breathing
Number of subjects: 52
Study 34654028 — intervention group
Group type: COMPARATOR
Intervention: HRV‐Sham‐BF
Number of subjects: 52
Study 34148051 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar Recruitment Maneuver (RM) at 30 cmH₂O for 30 s
Number of subjects: 59
Study 34148051 — intervention group
Group type: COMPARATOR
Intervention: Sham Maneuver (SM) at 5 cmH₂O for 30 s
Number of subjects: 59
Study 32785986 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling and 5-fluorouracil solution (group C)
Number of subjects: 90
Study 32785986 — intervention group
Group type: COMPARATOR
Intervention: Intralesional 5-fluorouracil (group A)
Number of subjects: 90
Study 32785986 — intervention group
Group type: COMPARATOR
Intervention: Microneedling (group B)
Number of subjects: 90
Study 32785986 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 35152175 — intervention group
Group type: EXPERIMENTAL
Intervention: PreEMPT (n = 8)
Number of subjects: 16
Study 35152175 — intervention group
Group type: COMPARATOR
Intervention: Usual Physiotherapy Care (UPC) (n = 8)
Number of subjects: 16
Study 33568383 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat (70 mg oral, thrice-weekly)
Number of subjects: 2781
Study 33568383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2781
Study 33568383 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat (in patients with elevated high-sensitivity C-reactive protein)
Number of subjects: 2781
Study 33568383 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in patients with elevated high-sensitivity C-reactive protein)
Number of subjects: 2781
Study 33568383 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 2781
Study 32710452 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye examination adherence (biennial guideline)
Number of subjects: 24832
Study 32710452 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye examination adherence (annual guideline)
Number of subjects: 24832
Study 32710452 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with non-adherence
Number of subjects: 24832
Study 35419530 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous adipose‐derived mesenchymal stem cells (AMSCs) delivered locally to the adventitia of the fistula.
Number of subjects: 0
Study 35419530 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified.
Number of subjects: 0
Study 35710228 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and photobiomodulation
Number of subjects: 36
Study 35710228 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and ultrasound
Number of subjects: 36
Study 35710228 — intervention group
Group type: COMPARATOR
Intervention: Exercise control group
Number of subjects: 36
Study 34914617 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based program with health promotion officer (HPO) support
Number of subjects: 22
Study 34914617 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 22
Study 34914617 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based program
Number of subjects: 22
Study 34914617 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based program and implementation support strategies
Number of subjects: 22
Study 36271847 — intervention group
Group type: EXPERIMENTAL
Intervention: 5A laboratory risk score model based on preoperative variables (older age, larger body mass index, lower platelet-neutrophile ratio, higher lymphocyte-monocyte ratio, higher D-dimer, lower fibrinogen, lower estimated glomerular filtration rate)
Number of subjects: 2397
Study 36271847 — intervention group
Group type: EXPERIMENTAL
Intervention: Low risk patients
Number of subjects: 2397
Study 35137458 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH (37.5 µg of Lecirelin)
Number of subjects: 39
Study 35137458 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG (1000 I.U)
Number of subjects: 39
Study 35137458 — intervention group
Group type: COMPARATOR
Intervention: Control (1 mL of physiological saline solution)
Number of subjects: 39
Study 34052828 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral minocycline 100 mg bid for 8 weeks
Number of subjects: 21
Study 34052828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 34981516 — intervention group
Group type: EXPERIMENTAL
Intervention: Krill oil (KO) - 7 capsules per day (1.27g n-3 PUFA)
Number of subjects: 11
Study 34981516 — intervention group
Group type: COMPARATOR
Intervention: Fish oil (FO) - 5 capsules per day (1.44g n-3 PUFA)
Number of subjects: 11
Study 32997836 — intervention group
Group type: EXPERIMENTAL
Intervention: SCL (two-stage crown lengthening)
Number of subjects: 30
Study 32997836 — intervention group
Group type: COMPARATOR
Intervention: CCL (one-stage crown lengthening)
Number of subjects: 30
Study 36351665 — intervention group
Group type: EXPERIMENTAL
Intervention: Air purifier with a high‐efficiency particulate air filter
Number of subjects: 30
Study 36351665 — intervention group
Group type: COMPARATOR
Intervention: Air purifier with a placebo filter
Number of subjects: 30
Study 33999936 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey on demographics, clinical data, lifestyles, and cognitive status
Number of subjects: 191
Study 33999936 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive clinical examination including neurological and cognitive testing, MRI, and EEG
Number of subjects: 191
Study 32598397 — intervention group
Group type: COMPARATOR
Intervention: Designated disadvantaged schools
Number of subjects: 1215
Study 32598397 — intervention group
Group type: EXPERIMENTAL
Intervention: Irish adolescents (girls)
Number of subjects: 1215
Study 32598397 — intervention group
Group type: EXPERIMENTAL
Intervention: Irish adolescents (boys)
Number of subjects: 1215